病毒样颗粒疫苗可防止RSV疫苗增强性呼吸系统疾病

2017-11-25 MedSci MedSci原创

根据乔治亚州立大学(Georgia State University)领导的一项研究,研究人员发现,一种类似病毒的颗粒疫苗可以启动人体的免疫反应,并预防患有呼吸道合胞病毒(RSV)的患者暴露于RSV中导致的严重呼吸道疾病。本研究为甲醛灭活呼吸道合胞病毒(FI-RSV)疫苗提供了一种解决方案,该疫苗不能保护儿童,而是在RSV感染后引起严重的呼吸道疾病,呼吸道合胞病毒疫苗增强性疾病(ERD)。研究人员


根据乔治亚州立大学(Georgia State University)领导的一项研究,研究人员发现,一种类似病毒的颗粒疫苗可以启动人体的免疫反应,并预防患有呼吸道合胞病毒(RSV)的患者暴露于RSV中导致的严重呼吸道疾病。

本研究为甲醛灭活呼吸道合胞病毒(FI-RSV)疫苗提供了一种解决方案,该疫苗不能保护儿童,而是在RSV感染后引起严重的呼吸道疾病,呼吸道合胞病毒疫苗增强性疾病(ERD)。
研究人员发现,在使用Fl - RSV疫苗之前,使用含有病毒的病毒颗粒含有RSV融合蛋白,并将小鼠暴露在RSV中,从而避免了FI-RSV疫苗增强的肺部炎症和对嗜酸性粒细胞的侵袭,这是一种对抗疾病的白细胞。

FI-RSV疫苗接种导致的ERD中80%的患者住院,其中两名儿童死亡。 其特征在于气道产生粘液,严重的肺部炎症,T辅助细胞 2型(Th2)细胞的免疫应答以及嗜酸性粒细胞渗入呼吸道内层。
乔治亚州生物医学科学研究所的首席作者兼教授Sang - moo Kang博士说:"这项研究提供了对由FI-RSV疫苗接种和开发安全RSV疫苗造成ERD的机制研究。"

"我们证明,用呈递RSV融合蛋白的病毒样颗粒引发小鼠免疫应答转移从而预防ERD的发生。一种预防ERD的保护性先天性和适应性免疫反应的疫苗仍有待开发,但是我们的研究结果可能为创建具有这些功能的安全疫苗铺平了道路。"

研究人员用不同的方法作用于对照鼠和两组免疫小鼠。在接受FI-RSV疫苗之前,免疫小鼠接受了两种引物中的一种。一组小鼠接种了FI-RSV疫苗,然后给予FI-RSV增强。另一组首先用含有RSV融合蛋白的疫苗样颗粒预处理,然后给予FI-RSV加强。免疫接种三周后采集血液样本。

15周后,从两免疫组和对照组小鼠的小鼠感染RSV确定预防RSV疗效评估ERD。监测体重变化,收集支气管肺泡灌洗液进行病毒滴度测定,并取肺组织进行组织学和细胞分析。

这项研究结果发表在《Virology》杂志上。


此文系梅斯医学(MedSci)原创整理编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=266807, encodeId=965d26680e21, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Dec 04 22:21:39 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419006, encodeId=435d1419006cd, content=<a href='/topic/show?id=ab4d3969143' target=_blank style='color:#2F92EE;'>#呼吸系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39691, encryptionId=ab4d3969143, topicName=呼吸系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75de3457664, createdName=医生2395, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507509, encodeId=a43b150e509da, content=<a href='/topic/show?id=d33f15e143f' target=_blank style='color:#2F92EE;'>#RSV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15714, encryptionId=d33f15e143f, topicName=RSV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f939898798, createdName=feather81, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264221, encodeId=6d8d264221af, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat Nov 25 17:21:00 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-12-04 changjiu

    学习一下谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=266807, encodeId=965d26680e21, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Dec 04 22:21:39 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419006, encodeId=435d1419006cd, content=<a href='/topic/show?id=ab4d3969143' target=_blank style='color:#2F92EE;'>#呼吸系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39691, encryptionId=ab4d3969143, topicName=呼吸系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75de3457664, createdName=医生2395, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507509, encodeId=a43b150e509da, content=<a href='/topic/show?id=d33f15e143f' target=_blank style='color:#2F92EE;'>#RSV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15714, encryptionId=d33f15e143f, topicName=RSV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f939898798, createdName=feather81, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264221, encodeId=6d8d264221af, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat Nov 25 17:21:00 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=266807, encodeId=965d26680e21, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Dec 04 22:21:39 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419006, encodeId=435d1419006cd, content=<a href='/topic/show?id=ab4d3969143' target=_blank style='color:#2F92EE;'>#呼吸系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39691, encryptionId=ab4d3969143, topicName=呼吸系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75de3457664, createdName=医生2395, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507509, encodeId=a43b150e509da, content=<a href='/topic/show?id=d33f15e143f' target=_blank style='color:#2F92EE;'>#RSV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15714, encryptionId=d33f15e143f, topicName=RSV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f939898798, createdName=feather81, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264221, encodeId=6d8d264221af, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat Nov 25 17:21:00 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-11-27 feather81
  4. [GetPortalCommentsPageByObjectIdResponse(id=266807, encodeId=965d26680e21, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Dec 04 22:21:39 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419006, encodeId=435d1419006cd, content=<a href='/topic/show?id=ab4d3969143' target=_blank style='color:#2F92EE;'>#呼吸系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39691, encryptionId=ab4d3969143, topicName=呼吸系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75de3457664, createdName=医生2395, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507509, encodeId=a43b150e509da, content=<a href='/topic/show?id=d33f15e143f' target=_blank style='color:#2F92EE;'>#RSV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15714, encryptionId=d33f15e143f, topicName=RSV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f939898798, createdName=feather81, createdTime=Mon Nov 27 08:08:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264221, encodeId=6d8d264221af, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat Nov 25 17:21:00 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-11-25 changjiu

    学习一下谢谢

    0